** Shares of Apollo Hospitals APLH.NS rise as much as 1.7%
to an all-time high of 6,028.95 rupees
** Nomura maintains "buy" rating while raising PT to 6,724
rupees from 5,796 rupees, a 13.5% premium to its last close
** APLH on track for fourth straight session of gains; stock
adds 3.5% so far this week
** Brokerage expects Healthco, Apollo's pharmacy and 24x7
platform, to achieve EBITDA break-even in Q4FY24
** Adds, market share shift and store expansions to result
in 20% growth for APLH
** APLH trading 1.6% above its median PT of 6,097.50 rupees
- LSEG
** Analysts' avg rating on APLH, rivals Max Healthcare
MAXE.NS and Fortis Healthcare FOHE.NS at "buy" - LSEG
** APLH's 27% climb in 2023 lags MAXE's 56% and FOHE' ~47%
jump
(Reporting by Kashish Tandon)
((kashish.tandon@thomsonreuters.com))